Capital Group Investment Management PTE. LTD. decreased its holdings in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 38.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 28,831 shares of the company’s stock after selling 18,077 shares during the period. Capital Group Investment Management PTE. LTD.’s holdings in Corteva were worth $1,933,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. JPL Wealth Management LLC bought a new stake in Corteva during the third quarter valued at $25,000. Redmont Wealth Advisors LLC bought a new stake in Corteva during the third quarter valued at $29,000. Jackson Grant Investment Advisers Inc. boosted its stake in Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after buying an additional 213 shares during the period. Basepoint Wealth LLC bought a new stake in Corteva during the fourth quarter valued at $30,000. Finally, KERR FINANCIAL PLANNING Corp bought a new stake in Corteva during the third quarter valued at $33,000. Institutional investors own 81.54% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on CTVA. Morgan Stanley lifted their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 28th. Oppenheimer raised their price target on Corteva from $86.00 to $89.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. Berenberg Bank raised their price target on Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research report on Thursday, March 26th. Wells Fargo & Company raised their price target on Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, April 21st. Finally, CICC Research raised their price target on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $88.67.
Corteva Trading Down 0.5%
NYSE CTVA opened at $77.06 on Friday. The stock’s 50-day simple moving average is $81.17 and its two-hundred day simple moving average is $74.94. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $85.63. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $51.54 billion, a price-to-earnings ratio of 45.33, a PEG ratio of 2.36 and a beta of 0.57.
Corteva (NYSE:CTVA – Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. During the same quarter last year, the business posted $1.13 earnings per share. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts forecast that Corteva, Inc. will post 3.72 EPS for the current fiscal year.
Corteva Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be issued a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s payout ratio is currently 42.35%.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Articles
- Five stocks we like better than Corteva
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
